SWOG clinical trial number
SWOG-8015

Evaluation of Two Combination Chemotherapy Programs Adriamycin and Cis-Platinum (AP) versus Adriamycin, Cis-Platinum plus VP 16-213 (VAP), in the Treatment of Extensive Squamous Cell Carcinoma of the Lung

Closed
Phase
Abbreviated Title
Evaluation of Two Combination Chemotherapy Programs Adriamycin and Cis-Platinum (AP) versus Adriamycin, Cis-Platinum plus VP 16-213 (VAP), in the Treatment of Extensive Squamous Cell Carcinoma of the…
Activated
08/07/1980
Closed
01/31/1983

Publication Information Expand/Collapse

1983

Evaluation of two combination chemotherapy programs: Adriamycin and Cis-Platinum (AP) versus Adriamycin, Cis-Platinum plus VP16-213 (VAP) in the treatment of extensive squamous cell carcinoma of the lung. A Southwest Oncology Group study. Phase III (preliminary data).

PN Grozea;B Hom;TT Chen;JJ Costanzi;SP Balcerzak;RM O'Bryan;M Lane;RL Stephens;SC Dodd-Taylor;RB Livingston In: 13th International Congress of Chemotherapy (Vienna, August 28-September 2).